NEW YORK (GenomeWeb News) – In vitro diagnostics developer BioMérieux has struck a strategic partnership with Hitachi High-Technologies to develop microbiology and molecular diagnostic systems, BioMérieux said today.
The companies will work together to develop new instruments to be made by Hitachi High-Technologies and distributed through BioMérieux’s worldwide commercial network. The partners did not disclose terms of the alliance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.